Clinical TrialsSearch results
Number of results: 614
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma (Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer)
- Patients with stageII-IV Mullerian Carcinoma (Ovarian Epithelial,Primary Peritoneal,or Fallopian Tube Cancer)
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Randomized phase III study of TS-1 alone versus TS-1 plus Lentinan(LNT) in advanced or recurrent gastric cancer (AGC)
- Advanced or recurrent gastric cancer (AGC)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2007-01-20
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04
Other
- Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
- gastric cancer with peritoneal metastasis
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07
Other
- Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)
- advanced or recurrent gastric cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-16
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).
- Non small cell lung cancer
- Kyoto Thoracic Oncology Research Group (KTORG)
- 2007-01-01
Other
- Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
- Stage IIIB/IV non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-01